Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rhodes

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Plos One|March 10, 2012
Endocrine disruptor regulation of microRNA expression in breast carcinoma cellsSyreeta L Tilghman, Melyssa R Bratton, H Chris Segar, et al.
Oncology Letters|June 29, 2012
Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancerLyndsay V Rhodes, Syreeta L Tilghman, Stephen M Boue, et al.
International Journal of Oncology|February 14, 2013
Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transitionJames W Antoon, Ashley M Nitzchke, Elizabeth C Martin, et al.
Cancer|July 21, 2017
A multidimensional view of racial differences in access to prostate cancer careCraig Evan Pollack, Katrina A Armstrong, Nandita Mitra, et al.
Oncology Letters|March 29, 2021
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cellsMargarite D Matossian, Steven Elliott, Lyndsay V Rhodes, et al.
Oncology Reports|October 6, 2011
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cellsLyndsay V Rhodes, Ashley M Nitschke, H Chris Segar, et al.
Experimental Cell Research|September 13, 2011
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cellsLyndsay V Rhodes, Melyssa R Bratton, Yun Zhu, et al.
The New England Journal of Medicine|July 2, 2004
Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogenChristina M Coyle, Louis M Weiss, Luther V Rhodes, et al.
Non-Coding RNA|April 17, 2018
Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform VariationAdrienne K Conger, Elizabeth C Martin, Thomas J Yan, et al.
Endocrinology|September 24, 2010
Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640James W Antoon, Martin D White, William D Meacham, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Plos One|March 10, 2012
Endocrine disruptor regulation of microRNA expression in breast carcinoma cellsSyreeta L Tilghman, Melyssa R Bratton, H Chris Segar, et al.
Oncology Letters|June 29, 2012
Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancerLyndsay V Rhodes, Syreeta L Tilghman, Stephen M Boue, et al.
International Journal of Oncology|February 14, 2013
Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transitionJames W Antoon, Ashley M Nitzchke, Elizabeth C Martin, et al.
Cancer|July 21, 2017
A multidimensional view of racial differences in access to prostate cancer careCraig Evan Pollack, Katrina A Armstrong, Nandita Mitra, et al.
Oncology Letters|March 29, 2021
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cellsMargarite D Matossian, Steven Elliott, Lyndsay V Rhodes, et al.
Oncology Reports|October 6, 2011
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cellsLyndsay V Rhodes, Ashley M Nitschke, H Chris Segar, et al.
Experimental Cell Research|September 13, 2011
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cellsLyndsay V Rhodes, Melyssa R Bratton, Yun Zhu, et al.
The New England Journal of Medicine|July 2, 2004
Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogenChristina M Coyle, Louis M Weiss, Luther V Rhodes, et al.
Non-Coding RNA|April 17, 2018
Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform VariationAdrienne K Conger, Elizabeth C Martin, Thomas J Yan, et al.
Endocrinology|September 24, 2010
Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640James W Antoon, Martin D White, William D Meacham, et al.
Pageof 20